Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
about
Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem useComparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.Pharmacokinetics and tolerability of single-dose intravenous ertapenem in infants, children, and adolescentsOccurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases.Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh modelErtapenem susceptibility of extended spectrum beta-lactamase-producing organisms.Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial.Ertapenem: review of a new carbapenem.Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.Carbapenems in the USA: focus on doripenem.The current state of multidrug-resistant gram-negative bacilli in North America.Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.Ertapenem resistance of Escherichia coli.Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.A pharmacokinetic-pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposure.VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals.Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli.Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency.Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
P2860
Q28299749-C7189A1D-F1E1-485D-8A09-6ADB682BCB90Q33291234-E3493C4D-1103-429F-AB73-BE027859B501Q34244192-13C3647E-5EA8-4A12-8324-B3023C6A2500Q34348830-C38A15A1-395A-44DB-923C-0BD25EBF4297Q34753336-2425E095-33A1-4212-8FF2-01BB9EE4448BQ35758849-720BC176-F073-48E5-ACF7-7C5445B9918DQ35846434-11147EF2-F6F0-4712-A44D-F9E6988579A3Q35928948-7E02E2DF-EFBE-4705-B27C-276E945A0276Q36066200-AC19E8A7-A708-49F7-8E43-8BB066C5D8A4Q36298715-2EFA31A7-F36A-4CF7-B646-737C2A059228Q36670187-3F46A99A-231A-4B69-B343-0A44B311193EQ36960048-6CF77B46-44CA-4337-876C-C59B0E4882BAQ37069191-D6ADF897-5029-4D0F-A3DF-0289FE5E8E06Q37120635-F680EDDF-C267-4CCB-BC09-16961CFEB0BAQ37302659-9CB86FF7-5248-4A9E-A87E-1CEC6F1E7312Q38454462-F46DE61E-99BC-4919-B75D-57822A1675ABQ38899499-17C2983B-E31D-4A71-B389-1B87AA0A3D7BQ39665401-C8EC5D8F-E1A6-4DB3-AA96-69989145ABC9Q39848524-AA8C1162-BB7B-4F1D-A952-149391D4A448Q40945545-44EAFE8D-82C0-4DC1-9020-3C0A665694E3Q41946181-5AF597F5-1B85-49AC-BF6F-BCEF65B421FEQ43194349-823FC0D4-B47C-48FB-A6BE-10223BB6C748Q45800962-655FDF40-35F9-4B29-9641-9DBE597A5A82Q46113955-3D6E1268-C7A2-4ABC-8AC4-88DAFC2D0B88Q46402003-5B6A595C-856B-43F7-A715-C80976413BD0Q46784239-D75917E0-2013-484B-B051-C908C11C2FFD
P2860
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@ast
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@en
type
label
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@ast
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@en
prefLabel
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@ast
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@en
P2093
P2860
P1476
Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.10.2831-2837.2001
P407
P577
2001-10-01T00:00:00Z